ACADIA Pharmaceuticals Inc (ACAD)

Debt-to-assets ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Long-term debt	US$ in thousands	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total assets	US$ in thousands	1,187,760	976,868	914,099	855,103	748,956	632,540	642,769	655,305	587,812	602,491	612,766	624,251	700,122	717,673	724,429	755,173	782,616	795,664	759,649	747,450
Debt-to-assets ratio		0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

December 31, 2024 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $1,187,760K
= 0.00

The debt-to-assets ratio for ACADIA Pharmaceuticals Inc has consistently remained at 0.00 over the past few years, indicating that the company has not used debt to finance its assets. A debt-to-assets ratio of 0.00 suggests that the company has used entirely equity financing to fund its operations and acquisitions, which can be viewed positively as it implies a lower financial risk due to the absence of debt obligations. This financial stability may be attractive to investors and creditors, as it indicates a strong financial position and the ability to weather economic downturns. However, it's important to note that while a low debt-to-assets ratio is generally favorable, it may also suggest missed opportunities for leveraging debt to potentially enhance returns on investment. Overall, ACADIA Pharmaceuticals Inc's consistent 0.00 debt-to-assets ratio demonstrates a prudent approach to capital structure and financial management.